Physician profile
Barrett Dow Conner
NPI 1326046673
$8,105.85
in general payments reported to CMS, 2019-2025
42 companies · $1,742 in 2025
The $1,742 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,110 · 2020: $627 · 2021: $810 · 2022: $1,355 · 2023: $1,219 · 2024: $1,243 · 2025: $1,742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,193 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,193.13 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $1,773.21 | 2019-2025 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $994.33 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Glaxosmithkline, LLC. | $772.21 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $594.39 | 2019-2025 | Airsupra, Fasenra, Breztri |
| Insmed, INC. | $450.70 | 2019-2025 | Arikayce |
| Merck Sharp & Dohme LLC | $423.06 | 2019-2025 | Winrevair, Zerbaxa, Keytruda |
| Regeneron Healthcare Solutions, INC. | $366.40 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $341.20 | 2021-2025 | Tyvaso, Tyvaso |
| Genzyme Corporation | $315.33 | 2019-2025 | |
| Grifols USA, LLC | $199.77 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $161.28 | 2019-2024 | Yupelri |
| Inspire Medical Systems, INC. | $149.57 | 2023-2025 | Inspire |
| Baxter Healthcare | $128.60 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Harmony Biosciences LLC | $121.86 | 2024-2025 | |
| Philips North America LLC | $120.78 | 2019-2025 | Vest Therapy Und |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barrett Conner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.